← Leaderboards
Ratko Djukanovic
University Of Southampton
$0
Attributed
$0
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$1,142,025 · 3
By mechanism
R01$1,142,025 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Immunologic Assay /Test”
- Jay B Jackson · Johns Hopkins University$20,808,099
- Stanley B Prusiner · University Of California San Francisco$6,710,015
- Paul Yager · University Of Washington$4,889,730
- Jonathan Smith · Alphavax Human Vaccines, Inc.$4,839,367
- David Curtis Mohr · University Of California San Francisco$4,492,846
- Anup K Singh · Sandia Corp-Sandia National Laboratories$4,200,000
Research focus
Immunologic Assay /TestChronic Obstructive Pulmonary DiseaseRespiratory EpitheliumEnzyme Linked Immunosorbent AssayAntibodyHigh Throughput TechnologyHuman SubjectImmunocytochemistryImmunoprecipitationInflammationLaboratory RabbitLungLung LavagePlethysmographyPrognosisProtein IsoformsProteinsProteomicsSmokingSpirometryAsthmaBiomarkerClinical ResearchGel Electrophoresis
Grant awards (10)
A proteomics approach in the study of novel COPD markers$250,787
R01 · FY2005 · HL
A Proteomics Approach in the Study of Novel COPD Markers - Cohort B$0
R01 · FY2005 · HL
A Proteomics Approach in the Study of Novel COPD Markers - Cohort A$0
R01 · FY2005 · HL
A proteomics approach in the study of novel COPD markers$265,110
R01 · FY2004 · HL
A Proteomics Approach in the Study of Novel COPD Markers - Cohort A$0
R01 · FY2004 · HL
A Proteomics Approach in the Study of Novel COPD Markers - Cohort B$0
R01 · FY2004 · HL
A proteomics approach in the study of novel COPD markers$309,750
R01 · FY2003 · HL
A Proteomics Approach in the Study of Novel COPD Markers - Domestic Cohort B$0
R01 · FY2003 · HL
A Proteomics Approach in the Study of Novel COPD Markers - Foreign Cohort A$0
R01 · FY2003 · HL
A proteomics approach in the study of novel COPD markers$316,378
R01 · FY2002 · HL